ACCD
Accolade Inc
Price:  
7.02 
USD
Volume:  
4,585,688.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Accolade EV/EBITDA

-170.7%
Upside

As of 2025-04-29, the EV/EBITDA ratio of Accolade Inc (ACCD) is -13.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Accolade's latest enterprise value is 599.05 mil USD. Accolade's TTM EBITDA according to its financial statements is -44.36 mil USD. Dividing these 2 quantities gives us the above Accolade EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 6.7x - 11.2x 8.4x
Forward P/E multiples 7.3x - 13.3x 8.9x
Fair Price (4.23) - (6.35) (4.97)
Upside -160.2% - -190.4% -170.7%
7.02 USD
Stock Price
(4.97) USD
Fair Price

Accolade EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-04-07 -13.50
2025-04-04 -13.52
2025-04-03 -13.49
2025-04-02 -13.45
2025-04-01 -13.45
2025-03-31 -13.43
2025-03-28 -13.45
2025-03-27 -13.47
2025-03-26 -13.45
2025-03-25 -13.45
2025-03-24 -13.47
2025-03-21 -13.49
2025-03-20 -13.45
2025-03-19 -13.45
2025-03-18 -13.47
2025-03-17 -13.47
2025-03-14 -13.43
2025-03-13 -13.43
2025-03-12 -13.43
2025-03-11 -13.39
2025-03-10 -13.39
2025-03-07 -13.41
2025-03-06 -13.41
2025-03-05 -13.41
2025-03-04 -13.38
2025-03-03 -13.38
2025-02-28 -13.41
2025-02-27 -13.39
2025-02-26 -13.39
2025-02-25 -13.38
2025-02-24 -13.32
2025-02-21 -13.34
2025-02-20 -13.30
2025-02-19 -13.26
2025-02-18 -13.30
2025-02-14 -13.28
2025-02-13 -13.28
2025-02-12 -13.28
2025-02-11 -13.23
2025-02-10 -13.26
2025-02-07 -13.25
2025-02-06 -13.25
2025-02-05 -13.28
2025-02-04 -13.30
2025-02-03 -13.36
2025-01-31 -13.26
2025-01-30 -13.25
2025-01-29 -13.25
2025-01-28 -13.25
2025-01-27 -13.28